Dubai, Émirats arabes unis
CHF 3,990,600 - CHF 7,981,200
Data Analytics and Business Intelligence Expert, Artificial General Intelligence and Crypto asset Anti-Money laundering. Decentralised finance. ACAMS Certified.
Blockchain, Crypto Assets, DeFi, Anti-Money Laundering, AI
Oncology therapeutics redefined Onconetix, Inc. (Nasdaq: ONCO) (formerly Blue Water Biotech, Inc. (BWV)) is a commercial stage biotechnology company focused on the research, development and commercialization of proprietary therapeutics, diagnostics and services for clinicians and patients for oncology. The Company currently has Entadfi®, an FDA approved, oral therapeutic for the treatment of benign prostatic hyperplasia (BPH), a disorder of the prostate, and Proclarix®, an advanced proprietary diagnostic system for screening and diagnosis for men with indeterminate Prostate Specific Antigen (PSA) assessments in prostate cancer oncology. For more information, visit www.onconetix.com.
Innovating Healthcare and Life Sciences from Every Angle Throughout healthcare, providers, payers, and biopharma professionals are working hard to improve the system and deliver the best outcomes for patients and consumers. True change agents know it can’t be done alone. We strive to partner with you to reinforce your progress with our breakthrough technology and healthcare know-how. Together we’ll create an unshakeable system where you are empowered to do the work needed to transform healthcare.
Finance
Software
Technologie
Agriculture
Services Commerciaux
Éducation et Formation
Énergie et Ressources Naturelles
Divertissement & Loisirs
Mode et Beauté
Alimentation et Boissons
Restaurants et Bars
Fabrication et Ingénierie
Médias
Médecine et Pharma
Services Personnels
Produits et Inventions
Immobilier
Vente au Détail
Ventes et Marketing
Transport
AIN aide les investisseurs et les entrepreneurs à établir des relations durables et rentables en vue de créer de meilleures entreprises et un avenir plus prometteur.